Cobalt Blue and Glomar Minerals Progress Project Infinity Nodule Collaboration

Early-stage hype, not near-term value—watch for real milestones before investing.

What the company is saying

Cobalt Blue (ASX:COB) is positioning itself as a first-mover in deep-sea critical minerals processing through its Project Infinity partnership with Glomar. The company’s core narrative is that it is making 'solid progress' toward building and operating the world’s first commercial refinery for polymetallic nodules from the Clarion-Clipperton Zone (CCZ), a region between Hawaii and Mexico. The announcement emphasizes the formation of the consortium in March, the advancement of site selection (with a shortlist of four brownfield locations in Texas, North Carolina, and Louisiana), and the commencement of bench-scale test work on a 25 kg nodule sample at its Broken Hill Technology Centre. It claims that initial data shows strong multi-metal grades, suggesting these nodules could be a competitive alternative to land-based resources, though no assay results or comparative data are disclosed. The company highlights Glomar’s ownership of large CCZ tenements (133,000 sq km plus a 19.9% interest in another 58,000 sq km) and over US$40 million invested since 2012 in surveys and technical studies. The partners are targeting annual processing of 200,000 tonnes of nodules and 7,500 tonnes of cobalt hydroxide, with future plans for multi-metal recovery and battery-grade products. The tone is upbeat and forward-looking, with management projecting confidence but providing little in the way of hard financials or timelines. Notable individuals named include Dr Andrew Tong (CEO) and Robbie Diamond (executive chair), but the announcement does not detail their backgrounds or institutional affiliations, nor does it mention any external validation or third-party investment. The narrative fits a classic early-stage resource development IR strategy: stress unique positioning and potential, downplay risks, and omit specifics on funding, permitting, or commercial agreements. There is no evidence of a shift in messaging, but the lack of historical context makes it impossible to assess changes over time.

What the data suggests

The only concrete numbers disclosed are: the consortium was formed in March; four US brownfield sites are shortlisted; bench-scale test work is underway on a 25 kg sample; Glomar holds 133,000 sq km of CCZ tenements and a 19.9% stake in another 58,000 sq km; and over US$40 million has been invested in these licences since 2012. There are no figures for revenue, profit, cash flow, or capital structure, nor any period-over-period comparisons or operational metrics. The target to process 200,000 tonnes of nodules and produce 7,500 tonnes of cobalt hydroxide per year is purely aspirational, with no evidence of feasibility, funding, or permitting. The financial trajectory is impossible to assess from this announcement, as there is no disclosure of costs, projected returns, or even a timeline for construction or production. The only financial signal is the historical investment by Glomar, which, while substantial, is sunk cost and does not speak to future capital requirements or project economics. The quality of disclosure is poor: key metrics are missing, and the data provided is insufficient for any rigorous financial analysis. An independent analyst would conclude that, based on the numbers alone, this is an early-stage project with no near-term commercial or financial visibility.

Analysis

The announcement adopts a positive tone, highlighting 'solid progress' and ambitious project goals, but the measurable progress is limited to early-stage activities such as site shortlisting and bench-scale test work on a small sample. Most key claims are forward-looking, including the construction and operation of a commercial refinery, targeted production rates, and future surveys and studies. There is no evidence of binding agreements, committed funding for construction, or definitive feasibility results. The only disclosed capital outlay is a cumulative US$40 million spent on exploration and studies since 2012, with no immediate earnings impact or revenue. The gap between narrative and evidence is widened by aspirational language about being the 'world’s first' and targeting multi-metal production, without supporting data or timelines for delivery. The data supports only early-stage project advancement, not the realisation of commercial or financial benefits.

Risk flags

• ●Execution risk is high: The project is at an early stage, with only site shortlisting and bench-scale test work completed. There is no evidence of construction, permitting, or funding for the proposed refinery, making the path to commercial operation long and uncertain.
• ●Financial disclosure risk: The announcement provides no information on revenues, costs, cash flow, or capital structure. Without these details, investors cannot assess the company’s financial health or the economic viability of Project Infinity.
• ●Forward-looking bias: The majority of claims are aspirational, including production targets and multi-metal recovery plans. These are not supported by feasibility studies, binding agreements, or disclosed timelines, increasing the risk that they may never be realized.
• ●Capital intensity risk: The project will require significant additional investment beyond the US$40 million already spent on exploration and studies. The absence of committed funding or cost estimates raises concerns about future dilution or financing hurdles.
• ●Data quality risk: Key operational and financial metrics are missing, and the only quantitative data relates to historical exploration spend and land holdings. This lack of transparency makes it difficult for investors to make informed decisions.
• ●Geographic and regulatory risk: The project involves deep-sea mining in the Clarion-Clipperton Zone, a region with complex international and environmental regulations. There is no mention of permitting status or regulatory engagement, which could delay or derail the project.
• ●Timeline risk: With no disclosed schedule for construction or production, and only early-stage activities underway, the timeline to value realization is likely to be several years at best. Investors face the risk of capital being tied up in a long-dated, uncertain project.
• ●Management signaling risk: While notable individuals such as Dr Andrew Tong and Robbie Diamond are named, there is no evidence of external institutional investment or third-party validation. Management’s confidence is not backed by independent endorsement or binding commitments.

Bottom line

For investors, this announcement signals that Cobalt Blue and Glomar are still in the very early stages of developing Project Infinity, with progress limited to site selection and small-scale test work. The narrative is ambitious, but the evidence is thin—there are no financials, no binding agreements, no feasibility results, and no disclosed timeline for construction or production. The only hard number is Glomar’s historical US$40 million spend on exploration, which does not guarantee future project success or funding. The involvement of named executives does not equate to institutional backing or external validation, and there is no mention of offtake, EPC, or financing agreements. To change this assessment, the company would need to disclose definitive feasibility study results, signed construction or offtake contracts, and a clear, funded path to production. Key metrics to watch in the next reporting period include progress on permitting, funding commitments, and any movement beyond bench-scale testing. At this stage, the information is not actionable for investment—this is a story to monitor, not a signal to buy. The single most important takeaway is that all commercial and financial upside remains speculative and distant; only tangible, near-term milestones should move the investment needle.

Announcement summary

(ASX:COB) Cobalt Blue has reported solid progress on its Project Infinity partnership with US critical minerals company Glomar, focused on constructing and operating the world’s first commercial refinery to process polymetallic nodules from the Clarion-Clipperton Zone (CCZ) in the Pacific Ocean between Hawaii and Mexico. Since the consortium was formed in March, the partners have advanced the site selection process, creating a shortlist of four potential brownfields locations across Texas, North Carolina, and Louisiana. Bench-scale test work has commenced on a 25 kilogram sample of CCZ nodules at Cobalt’s Broken Hill Technology Centre (BHTC) to assist in determining the optimal starter feed and defining the scope of work for a planned pre-feasibility study. Glomar Minerals owns the UK1 and UK2 exploration tenements within the CCZ over an area of approximately 133,000 square kilometres and holds a 19.9% interest in a third licence for an additional 58,000 sq km. The company has invested more than US$40 million on the licences since 2012 covering oceanographic and environmental surveys plus technical studies including harvesting and processing. The partners aim to process 200,000 tonnes of polymetallic nodules and 7,500t of cobalt hydroxide per annum. The company projects that new surveys have been planned for later this year and samples will be sent to the BHTC for piloting test work as part of the feasibility studies for Project Infinity.

Disagree with this article?